DE2737630C2 - - Google Patents

Info

Publication number
DE2737630C2
DE2737630C2 DE19772737630 DE2737630A DE2737630C2 DE 2737630 C2 DE2737630 C2 DE 2737630C2 DE 19772737630 DE19772737630 DE 19772737630 DE 2737630 A DE2737630 A DE 2737630A DE 2737630 C2 DE2737630 C2 DE 2737630C2
Authority
DE
Germany
Prior art keywords
group
general formula
compound
propoxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19772737630
Other languages
German (de)
English (en)
Other versions
DE2737630A1 (de
Inventor
Wolfgang Dr.Rer.Nat. 6805 Heddesheim De Kampe
Walter-Gunar Dr.Rer.Nat. 6100 Darmstadt De Friebe
Fritz Dr.Phil. 6940 Weinheim De Wiedemann
Gisbert Dr.Med.Vet. 6944 Hemsbach De Sponer
Wolfgang Dr.Med.Vet. 6806 Viernheim De Bartsch
Karl Prof. Dr.Med. 6800 Mannheim De Dietmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19772737630 priority Critical patent/DE2737630A1/de
Priority to US05/846,057 priority patent/US4146630A/en
Priority to IL53323A priority patent/IL53323A/xx
Priority to NL7712220A priority patent/NL7712220A/xx
Priority to AR269873A priority patent/AR218643A1/es
Priority to YU02664/77A priority patent/YU266477A/xx
Priority to AU30466/77A priority patent/AU510284B2/en
Priority to CS777291A priority patent/CS228106B2/cs
Priority to DD7700201951A priority patent/DD133801A5/xx
Priority to FI773346A priority patent/FI62077C/fi
Priority to IT29456/77A priority patent/IT1087490B/it
Priority to GB46415/77A priority patent/GB1541547A/en
Priority to PL1977201997A priority patent/PL110782B1/pl
Priority to PL21334777A priority patent/PL111948B1/pl
Priority to PL1977213346A priority patent/PL112683B1/pl
Priority to CA290,495A priority patent/CA1086740A/en
Priority to CH1367177A priority patent/CH636099A5/de
Priority to PL21334877A priority patent/PL112154B1/pl
Priority to SE7712720A priority patent/SE7712720L/xx
Priority to HU77BO1689A priority patent/HU177410B/hu
Priority to FR7733907A priority patent/FR2370744A1/fr
Priority to LU7778498A priority patent/LU78498A1/xx
Priority to JP13559177A priority patent/JPS5363385A/ja
Priority to DK500677A priority patent/DK500677A/da
Priority to AT808277A priority patent/AT361476B/de
Priority to CS785459A priority patent/CS228108B2/cs
Priority to CS785460A priority patent/CS228109B2/cs
Priority to CS785461A priority patent/CS228110B2/cs
Priority to ES472747A priority patent/ES472747A1/es
Priority to ES472746A priority patent/ES472746A1/es
Priority to SU782674802A priority patent/SU826955A3/ru
Priority to SU782675553A priority patent/SU890975A3/ru
Priority to AR275657A priority patent/AR221081A1/es
Priority to AR275655A priority patent/AR221868A1/es
Publication of DE2737630A1 publication Critical patent/DE2737630A1/de
Priority to AT649979A priority patent/AT362373B/de
Priority to AT650079A priority patent/AT362374B/de
Priority to AT649879A priority patent/AT361479B/de
Priority to CH367682A priority patent/CH639086A5/de
Priority to CH233783A priority patent/CH643554A5/de
Priority to YU01289/83A priority patent/YU128983A/xx
Priority to YU01288/83A priority patent/YU128883A/xx
Application granted granted Critical
Publication of DE2737630C2 publication Critical patent/DE2737630C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19772737630 1976-11-12 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel Granted DE2737630A1 (de)

Priority Applications (41)

Application Number Priority Date Filing Date Title
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US05/846,057 US4146630A (en) 1976-11-12 1977-10-27 Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
NL7712220A NL7712220A (nl) 1976-11-12 1977-11-07 Nieuwe aminopropanolderivaten, werkwijze voor de bereiding van dergelijke derivaten en ge- neesmiddelen met deze derivaten als werkzame verbinding.
AR269873A AR218643A1 (es) 1976-11-12 1977-11-07 Procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,bezimidazol y benzotriazol y sus sales
YU02664/77A YU266477A (en) 1976-11-12 1977-11-07 Process for preparing amino propanols and salts thereof
IL53323A IL53323A (en) 1976-11-12 1977-11-07 1-(4-phenoxymethylpiperidino)-2-hydroxy-3-(indolyl(indazolyl,benzimidazolyl or benzotriazolyl)oxy)propanes,their preparation and pharmaceutical compositions containing them
AU30466/77A AU510284B2 (en) 1976-11-12 1977-11-08 3(-(4-phenoxymethyl piperidino)-propoxy) indole or indazole or benzimidazole or benzotriazole
CS777291A CS228106B2 (en) 1976-11-12 1977-11-08 Production of novel derivatives of 3-/4-phenoxymethylpiperidino/-propanol
DD7700201951A DD133801A5 (de) 1976-11-12 1977-11-08 Neue aminopropanolderivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FI773346A FI62077C (fi) 1976-11-12 1977-11-08 Foerfarande foer framstaellning av farmaceutiskt anvaendbara fenoximetylpiperidinopropanolderivat
IT29456/77A IT1087490B (it) 1976-11-12 1977-11-08 Derivati aminopropanolici,processo per la loro preparazione e farmaci che li contengono
GB46415/77A GB1541547A (en) 1976-11-12 1977-11-08 4-phenoxymethylpiperidine derivatives
PL21334777A PL111948B1 (en) 1977-08-20 1977-11-09 Method of manufacture of novel derivatives of aminopropanol
PL1977213346A PL112683B1 (en) 1976-11-12 1977-11-09 Process for preparing novel derivatives of aminopropanol
CA290,495A CA1086740A (en) 1976-11-12 1977-11-09 Piperidinopropyl derivatives and the preparation thereof
CH1367177A CH636099A5 (de) 1976-11-12 1977-11-09 Verfahren zur herstellung von piperidinopropanolderivaten.
PL21334877A PL112154B1 (en) 1977-08-20 1977-11-09 Method of preparation of novel aminopropanol derivatives
PL1977201997A PL110782B1 (en) 1976-11-12 1977-11-09 Method of producing new derivatives of aminopropanol
FR7733907A FR2370744A1 (fr) 1976-11-12 1977-11-10 Nouveaux derives d'aminopropanol, procede pour leur preparation et medicaments contenant ces composes
HU77BO1689A HU177410B (en) 1976-11-12 1977-11-10 Process for preparing new piperidino-propanol derivatives
SE7712720A SE7712720L (sv) 1976-11-12 1977-11-10 Piperidinopropylderivat
LU7778498A LU78498A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-11-12 1977-11-11
JP13559177A JPS5363385A (en) 1976-11-12 1977-11-11 Novel aminopropanole derivative process for preparing same and medicine having vasodilating and betaaacceptor interupiing efect
DK500677A DK500677A (da) 1976-11-12 1977-11-11 Aminopropanolderivater fremgangsmaade til fremstilling heraf og laegemidler indeholdende disse forbindelser
AT808277A AT361476B (de) 1976-11-12 1977-11-11 Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen
CS785459A CS228108B2 (cs) 1977-08-20 1978-08-21 Způsob výroby nových derivátů 3-(4-fenoxymethylpiperidino)propanolu
CS785460A CS228109B2 (cs) 1977-08-20 1978-08-21 Způsob výroby nových derivátů 3-(4-fenoxymethylpiperidino)propanolu
CS785461A CS228110B2 (en) 1976-11-12 1978-08-21 Production of novel derivatives of 3-/4-phenoxymethylpi
ES472746A ES472746A1 (es) 1976-11-12 1978-08-22 Procedimiento para la preparacion de derivados de aminopro- panol
ES472747A ES472747A1 (es) 1976-11-12 1978-08-22 Procedimiento para la preparacion de derivados de aminopro- panol
SU782674802A SU826955A3 (ru) 1976-11-12 1978-10-20 Способ получения производных аминопропанола или их солей 1
SU782675553A SU890975A3 (ru) 1976-11-12 1978-10-20 Способ получени производных аминопропанола или их солей
AR275657A AR221081A1 (es) 1976-11-12 1979-02-28 Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
AR275655A AR221868A1 (es) 1976-11-12 1979-02-28 Un procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,benzimidazol y benzotriazol y sus sales
AT649879A AT361479B (de) 1976-11-12 1979-10-04 Verfahren zur herstellung von neuen aminopro- panolderivaten und deren salzen
AT650079A AT362374B (de) 1977-08-20 1979-10-04 Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen
AT649979A AT362373B (de) 1977-08-20 1979-10-04 Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen
CH367682A CH639086A5 (de) 1976-11-12 1982-06-14 Verfahren zur herstellung von piperidinopropanolderivaten.
CH233783A CH643554A5 (de) 1976-11-12 1983-05-02 Verfahren zur herstellung von piperidinopropanolderivaten.
YU01289/83A YU128983A (en) 1976-11-12 1983-06-09 Process for preparing 4-(2-hydroxy-3-(4-phenoxy-methyl-pyperidino)-propoxy)indol and salts and esters thereof
YU01288/83A YU128883A (en) 1976-11-12 1983-06-09 Process for preparing 4-(2-hydroxy-3-(4-phenoxy-methyl-pyperidino)-propoxy)indol and salts and esters thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
DE2737630A1 DE2737630A1 (de) 1979-03-01
DE2737630C2 true DE2737630C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-11-05

Family

ID=6016909

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772737630 Granted DE2737630A1 (de) 1976-11-12 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Country Status (2)

Country Link
DE (1) DE2737630A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL111948B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8575364B2 (en) 2008-10-30 2013-11-05 Janssen Pharmaceutica Nv Modulators of serotonin receptor
US8642583B2 (en) 2008-10-30 2014-02-04 Janssen Pharmaceutica Nv Serotonin receptor modulators

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005828B1 (de) * 1978-06-06 1981-03-11 Hoechst Aktiengesellschaft Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
DE2834114A1 (de) * 1978-08-01 1980-02-14 Schering Ag Polyalkoxyphenylpyrrolidone iii, verfahren zu ihrer herstellung und ihre verwendung
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SE8003278L (sv) 1979-05-04 1980-11-05 Continental Pharma Fenyletylaminderivat
DE2939292A1 (de) * 1979-09-28 1981-04-09 Boehringer Mannheim Gmbh, 6800 Mannheim N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
DE3721260A1 (de) * 1987-06-27 1989-01-12 Beiersdorf Ag Neue indolylpropanole, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2651574A1 (de) * 1976-11-12 1978-05-18 Boehringer Mannheim Gmbh Ein neues aminopropanol-derivat und verfahren zu dessen herstellung

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8575364B2 (en) 2008-10-30 2013-11-05 Janssen Pharmaceutica Nv Modulators of serotonin receptor
US8642583B2 (en) 2008-10-30 2014-02-04 Janssen Pharmaceutica Nv Serotonin receptor modulators
US8957059B2 (en) 2008-10-30 2015-02-17 Janssen Pharmaceutica Nv Modulators of serotonin receptors
US9981909B2 (en) 2008-10-30 2018-05-29 Janssen Pharmaceutica Nv Serotonin receptor modulators

Also Published As

Publication number Publication date
DE2737630A1 (de) 1979-03-01
PL111948B1 (en) 1980-09-30
PL112154B1 (en) 1980-09-30

Similar Documents

Publication Publication Date Title
EP0648767B1 (de) Piperidine und Piperazine, die Wirkungen auf das z.n.s. Zeigen
DE2915037C3 (de) Neue N-substituierte Moranolinderivate
EP0043535B1 (de) Tricyclische Arylether, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
EP0013894B1 (de) Neue Arylether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE3132882A1 (de) Neue piperazinone, ihre herstellung und verwendung
DE3906920A1 (de) Piperazinderivate oder deren salze, verfahren zur herstellung derselben und pharmazeutische mittel mit einem gehalt derselben als wirkstoff
EP0221376B1 (de) N-substituierte Diphenylpiperidine
DE69530988T2 (de) Benzimidazolderivate mit dopaminerger wirkung
DE2737630C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH645892A5 (de) Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel.
CH636099A5 (de) Verfahren zur herstellung von piperidinopropanolderivaten.
DE3100575A1 (de) "neue benzoesaeuren, ihre herstellung und ihre verwendung als arzneimittel"
EP0000220A1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP1210335B1 (de) Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE1964421A1 (de) Verfahren zur Herstellung von aromatischen AEthern
EP0014928B1 (de) Neue Piperidinopropylderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69904849T2 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH626351A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3424586A1 (de) 3-aminocarbonylmethoxy-5-phenyl-pyrazol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE1720033A1 (de) Neue Indolderivate und Verfahren zu ihrer Herstellung
DE3642497A1 (de) Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
EP0088986B1 (de) Bicyclische Phenolether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
EP1220845B1 (de) Arylsulfonamid-substituierte benzimidazolderivate ihre verwendung als tryptase-inhibitoren
EP1220844B1 (de) Arylsulfonamid-substituierte benzimidazolderivate und ihre verwendung als tryptase-inhibitoren

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee